Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,699,609

« Back to Dashboard

Which drugs does patent 7,699,609 protect, and when does it expire?

Patent 7,699,609 protects ARESTIN and is included in one NDA.

This patent has sixteen patent family members in thirteen countries.

Summary for Patent: 7,699,609

Title:	Dispensing apparatus and cartridge with deformable tip
Abstract:	A device for the treatment of periodontal disease. The device includes a handle that has a configuration familiar to dental professionals and a cartridge that is locked into the handle when use, typically delivery of a composition to a periodontal pocket, is desired. The cartridge provides for effective delivery of compositions, such as agents, as its tip is deformable, typically from a circular to an oval shape so as to flatten. The deformation may be made either manually, by the dental professional, or upon contact with teeth or other tissues, whereby this flattened tip can penetrate deeply into periodontal pockets for quick and direct application of the composition, for example, therapeutic agents.
Inventor(s):	Lawter; James R. (Yardley, PA), Lanzilotti; Michael G. (Newtown, PA), Bates; Mark (Westwood, MA), Hunter; Gregory H. (Dover, MA)
Assignee:	Orapharma, Inc. (Warminster, PA)
Application Number:	10/763,632
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 7,699,609
Patent Claim Types: see list of patent claims	Device; Use;

Drugs Protected by US Patent 7,699,609

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Orapharma	ARESTIN	minocycline hydrochloride	POWDER, EXTENDED RELEASE;DENTAL	050781-001	Feb 16, 2001		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 7,699,609

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	039205	➤ Sign Up
Australia	2003223384	➤ Sign Up
Australia	2009201777	➤ Sign Up
Brazil	0308859	➤ Sign Up
Canada	2479995	➤ Sign Up
Colombia	5611079	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.